Einträge von Stege, Henner auf dem Publikationsserver

Haist, Maximilian , Stege, Henner, Lang, Berenice Mareen, Tsochataridou, Aikaterini, Salzmann, Martin, Mohr, Peter, Schadendorf, Dirk, Ugurel, Selma , Placke, Jan-Malte, Weichenthal, Michael , Gutzmer, Ralf , Leiter, Ulrike , Kaatz, Martin, Haferkamp, Sebastian, Berking, Carola, Heppt, Markus , Tschechne, Barbara, Schummer, Patrick, Gebhardt, Christoffer , Grabbe, Stephan und Loquai, Carmen (2022) Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry. Cancers 14 (22), S. 5543. Volltext nicht vorhanden.

Stege, Henner, Haist, Maximilian , Schultheis, Michael, Fleischer, Maria Isabel, Mohr, Peter, Meier, Friedegund, Schadendorf, Dirk, Ugurel, Selma, Livingstone, Elisabeth , Zimmer, Lisa , Herbst, Rudolf, Pföhler, Claudia, Kähler, Katharina, Weichenthal, Michael, Terheyden, Patrick, Nashan, Dorothée, Debus, Dirk, Kaatz, Martin, Ziller, Fabian, Haferkamp, Sebastian , Forschner, Andrea, Leiter, Ulrike, Kreuter, Alexander , Ulrich, Jens, Kleemann, Johannes, Bradfisch, Fabienne, Grabbe, Stephan und Loquai, Carmen (2021) Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma—A Retrospective Multicenter ADOReg Study. Cancers 13 (10), S. 2312. Volltext nicht vorhanden.

Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus und Zimmer, Lisa (2020) Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Journal for ImmunoTherapy of Cancer 8 (1), e000333. Volltext nicht vorhanden.